September 22, 2014 5:45 AM ET

Life Sciences Tools and Services

Company Overview of Knome, Inc.

Company Overview

Knome, Inc., a life sciences company, provides human genome interpretation software and services for academic, pharmaceutical, and biotech researchers in the United States and internationally. It offers tools and solutions that help researchers, drug developers, and clinicians determine the genetic basis of human disease and drug response. The company provides knomeCLINIC, a software suite that helps medical researchers and clinicians interpret human genomes for biological relevance; kGAP, a cloud-enabled genome informatics engine that automates the process of standardizing, distilling, annotating, and comparing sequence data; Desktop interpretation-support applications that allow medical re...

25 First Street

Suite 107

Cambridge, MA 02141

United States

Founded in 2007

Phone:

617-941-4130

Fax:

617-715-1050

Key Executives for Knome, Inc.

Chief Executive Officer
Co-Founder and Chairman
Co-Founder and Chairman of Scientific Advisory Board
Age: 60
Co-Founder
Senior Vice President
Compensation as of Fiscal Year 2014.

Knome, Inc. Key Developments

Knome Introduces KnoSYS(TM)100

Knome, Inc. announced that it is taking orders for the knoSYS(TM)100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes. The knoSYS(TM)100 was developed to help geneticists discover relevant genetic variation, investigate diseases of unknown cause, and create next generation in silico gene tests. Units will begin shipping in the fourth quarter of 2012. knoSYS(TM)100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes. The knoSYS(TM)100 was developed to help geneticists discover relevant genetic variation, investigate diseases of unknown cause, and create next generation in silico gene tests. Starting at $125,000, the knoSYS(TM)100 is based on Knome's big data informatics technology. The system will accept next generation sequence data from sequencers, including those sold by Illumina, Life Technologies and Complete Genomics.

Similar Private Companies By Industry

Company Name Region
PRA International Operations, Inc. United States
Eventus Diagnostics, Inc. United States
Cayman Chemical Company, Inc. United States
Platypus Technologies, LLC United States
International HealthCare, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Knome, Inc., please visit www.knome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.